Search Results 3131-3140 of 26253 for oral
... oral therapy) for 90 days prior to Baseline. Subject has pulmonary veno-occlusive disease. Malignancy diagnosed and/or treated within 5 years prior to ...
This study is designed to determine whether an oral perioperative medication ... orally administered imaging agent for the real-time detection and ...
... Oral and throat cancer, Laryngeal cancer, Skull base tumor, Oropharyngeal cancer. Show more areas of focus for Daniel J. Ma, M.D. ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
... oral opioids, and increased patient satisfaction. There are no reports of the use of Exparel in the ophthalmic literature. The investigators propose a ...
Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.
Bempedoic acid is an oral pro-drug that is activated in the liver and inhibits cholesterol synthesis in hepatocytes, but is not activated in skeletal muscle ...
Help your child rehydrate. Give your child an oral rehydration solution, available at pharmacies without a prescription. Talk to your doctor if you have ...
Fasting blood sugar of greater than 140 mg/dl, on no oral hypoglycemic agents and a hemoglobin A1C less than 13%. Stabilized patients on oral hypoglycemic ...
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary effectiveness of KIN-3248, an oral small molecule ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.